第一作者机构:[1]Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Chengdu, Peoples R China[2]Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China[3]Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing, Peoples R China[4]Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China[5]Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China[6]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China[7]Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China[8]Henan Canc Hosp, Zhengzhou, Peoples R China[9]Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Hunan Canc Hosp, Changsha, Peoples R China[10]Guangdong Med Univ, Ctr Canc, Affiliated Hosp, Zhanjiang, Peoples R China[11]Guangxi Med Univ, Canc Hosp, Nanning, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Chen Yungchang,Deng Yanhong,Ma Yutong,et al.Clinical and genomic distinction of class 1/2/3 BRAF-mutant colorectal cancer and differential prognosis[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA:
Chen, Yungchang,Deng, Yanhong,Ma, Yutong,Huang, He,Liu, Yang...&Lin, Tongyu.(2022).Clinical and genomic distinction of class 1/2/3 BRAF-mutant colorectal cancer and differential prognosis.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Chen, Yungchang,et al."Clinical and genomic distinction of class 1/2/3 BRAF-mutant colorectal cancer and differential prognosis".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)